
Addressing Diversity in MS Research and Care
Nearly three million people worldwide are living with multiple sclerosis (MS), affecting individuals from diverse geographical, ethnic, racial, and socio-economic backgrounds. This diversity raises im...
12 Des 202429min

Paediatric Multiple Sclerosis
While paediatric onset multiple sclerosis is relatively rare, it presents unique challenges. Extensive research efforts are taking place around the world to better understand the disease mechanism of ...
27 Nov 202424min

MS Prodrome: Implications and Future Research Directions
If you talk to someone living with MS about their journey, one of the first things they will tell you is that they knew something was wrong long before they received their diagnosis. While this anecdo...
7 Nov 202419min

Future MS Therapeutics
Significant progress has been made in multiple sclerosis (MS) treatments over the past 20 years. What does the next 20 years hold for MS therapies? What novel targets are being investigated? What clin...
24 Okt 202436min

MS Nurses at ECTRIMS 2024
Nurses play a specialised and unique role in the journey of people living with multiple sclerosis (MS). At ECTRIMS 2024, MS nurses showcased their experiences and insights into how to effectively supp...
10 Okt 202426min

Patient Community Day Highlights of ECTRIMS 2024: Part II
The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the ...
9 Okt 202417min

Patient Community Day Highlights of ECTRIMS 2024: Part I
The Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the ...
3 Okt 202416min

Day 3 Highlights of ECTRIMS 2024
Former ECTRIMS President and MS Journal Editor-in-Chief Alan Thompson and host Brett Drummond wrap up the last day of ECTRIMS 2024 with their final thoughts and insights.
20 Sep 202421min



















